Navigation Links
BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
Date:9/4/2007

safety, including lack of gastric lesions.

FlexNow Joint Formula was one of only seven dietary supplement products accepted by the FDA in 2004 to meet all the safety requirements under the Dietary Supplement Health and Education Act. FlexNow offers a full guarantee, complete relief in 30 days or complete refund.

About BSP Pharma

BSP Pharma Inc., a subsidiary of BSP Pharma A/S of Denmark, is based in Egg Harbor Township, NJ, and was formed in 2005 to bring the remarkable shea nut health products to market. BSP's CEO and President Leonard P. Smith has held senior level positions in the nutraceutical and pharmaceutical industry for more than 20 years. At Lactaid Inc. he led the company's flagship product, Lactaid(R), through explosive growth. While running Lactaid(R), Smith developed Beano(R), a successful legend in the nutraceutical field. For product availability and additional information visit the company's website http://www.FlexNow.us.

Lactaid(R) is a registered trademark of Johnson & Johnson.

Beano(R) is a registered trademark of GlaxoSmithKline.


'/>"/>
SOURCE BSP Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
(Date:8/28/2014)... 28, 2014 “This kit has an improved ... from 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin ... benefit to plant owners and USDA-GIPSA inspection agencies that have ... Testing can take place in a matter of minutes with ... plant test the feed and grain before accepting it, but ...
(Date:8/28/2014)... 28, 2014 The ability for organizations ... that will allow individuals to perform at the highest ... for employers looking to compete in this post–recession era. ... this trend, as the sector increasingly focuses on the ... which will have real results on the organization's development ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... on DAVID enable researchers to quickly and effectively use this invaluable ... ... OpenHelix today announced the availability of a new tutorial ... "DAVID." DAVID is a free, web-based bioinformatics tool that ...
... innovative measurement techniques, researchers from the Georgia Institute ... and Technology (NIST) have directly measured the unusual ... form of carbon that has tantalized and puzzled ... in this week,s issue of Science ,* ...
... (TSX:ONC, NASDAQ: ONCY ) announced today that data from ... at the 2009 American Society of Clinical Oncology (ASCO) Annual ... 29-June 2, 2009. The abstracts are available on the ASCO ... poster presentations, - Dr. Monica ...
Cached Biology Technology:New Online Tutorial for DAVID 2Graphene yields secrets to its extraordinary properties 2Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference 2
(Date:8/28/2014)... Mayo Clinic researcher and his collaborators have developed an ... the process of re-engineering cells for biomedical investigation. CellNet ... methods to aid stem cell engineering. Details of CellNet ... in two back-to-back papers in the journal Cell ... of uses for all types of cell-based investigations and ...
(Date:8/28/2014)... 2014  Privacy Advocate and Senior Staff Attorney at ... joins the lineup of biometric and mobile commerce experts ... Executive Summit in Tampa, Florida ... speakers include Steven Rahman, Director, Technology and Strategy at Samsung, ... The theme of this year,s event is Mobility at ...
(Date:8/28/2014)... Philadelphia, PA, August 28, 2014 Dyslexia, the ... States, is a neurological reading disability that occurs ... written language don,t function normally. , The use ... how brain activity is disrupted in dyslexia. However, ... small number of brain regions, leaving a gap ...
Breaking Biology News(10 mins):New tool aids stem cell engineering for medical research 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2Dyslexic readers have disrupted network connections in the brain 2
... American babies are born deaf. The numbers increase markedly with ... States experiencing some form of hearing loss. But ... in-laws, may soon be over. A new, landmark study ... Aviv University has uncovered one of the root causes of ...
... has hit pay dirt for Case Western Reserve University ... The researchers have created a line of patented ... that can take on the shape and size of ... trays to rubber ducky molds to clam-shell packaging molds ...
... severe dementia in patients with Alzheimer,s disease. Until ... the neuronal devastation in post mortem animal models, ... German Center for Neurodegenerative Disease at Ludwig-Maximilians-Universitaet (LMU) ... successfully observed this demise of nerve cells by ...
Cached Biology News:Scaling the wall of deafness 2Scaling the wall of deafness 3Case Western Reserve University engineers hit pay dirt with clay mixture 2Case Western Reserve University engineers hit pay dirt with clay mixture 3Alzheimer cell death in Zebrafish: Demise of neurons observed live for the first time 2
... Mouse anti-Yersinia pestis F1 antigen, Monoclonal ... ELISA: Use at an ... an assay dependent dilution. WB: Use ... molecular weight: 18 kDa. Not tested ...
Anti-Phospho-JKK/SEK1/MKK4 pAb Description: 100 g rabbit polyclonal antibody. Reacts with human/mouse/rat. Tested in WB. Research Focus: signal transduction Storage: -20C Shipping Tem...
... A - Fixation medium Reagent B - ... for fixing cells in suspension with Reagent ... Reagent B. This procedure gives antibodies access ... scatter characteristics of the cells intact. Specific ...
... formulated for covering tissue sections and cell preparations immunohistochemically stained ... , ... Application: Vision Mount ... that require an aqueous mounting medium, or those that do ...
Biology Products: